|
1
|
Keren R, Shah SS, Srivastava R, Rangel S,
Bendel-Stenzel M, Harik N, Hartley J, Lopez M, Seguias L, Tieder J,
et al: Comparative effectiveness of intravenous vs oral antibiotics
for postdischarge treatment of acute osteomyelitis in children.
JAMA Pediatr. 169:120–128. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Campagna S, Gonella S, Berchialla P,
Morano G, Rigo C, Zerla PA, Fuzzi R, Corona G, Storto S, Dimonte V
and Mussa B: Can peripherally inserted central catheters be safely
placed in patients with cancer receiving chemotherapy? A
retrospective study of almost 400,000 catheter-days. Oncologist.
24:e953–e959. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Taxbro K, Hammarskjöld F, Thelin B, Lewin
F, Hagman H, Hanberger H and Berg S: Clinical impact of
peripherally inserted central catheters vs implanted port catheters
in patients with cancer: An open-label, randomised, two-centre
trial. Br J Anaesth. 122:734–741. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yu D, Zhang K, Huang L, Zhao B, Zhang X,
Guo X, Li M, Gu Z, Fu G, Hu M, et al: Detection of peripherally
inserted central catheter (PICC) in chest X-ray images: A
multi-task deep learning model. Comput Methods Programs Biomed.
197(105674)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jumani K, Advani S, Reich NG, Gosey L and
Milstone AM: Risk factors for peripherally inserted central venous
catheter complications in children. JAMA Pediatr. 167:429–435.
2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Robinson A, Souied O, Bota AB, Levasseur
N, Stober C, Hilton J, Kamel D, Hutton B, Vandermeer L, Mazzarello
S, et al: Optimal vascular access strategies for patients receiving
chemotherapy for early-stage breast cancer: A systematic review.
Breast Cancer Res Treat. 171:607–620. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fallouh N, McGuirk HM, Flanders SA and
Chopra V: Peripherally inserted central catheter-associated deep
vein thrombosis: A narrative review. Am J Med. 128:722–738.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lv S, Liu Y, Wei G, Shi X, Chen S and
Zhang X: The anticoagulants rivaroxaban and low molecular weight
heparin prevent PICC-related upper extremity venous thrombosis in
cancer patients. Medicine (Baltimore). 98(e17894)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pu YL, Li ZS, Zhi XX, Shi YA, Meng AF,
Cheng F, Ali A, Li C, Fang H and Wang C: Complications and costs of
peripherally inserted central venous catheters compared with
implantable port catheters for cancer patients: A meta-analysis.
Cancer Nurs. 43:455–467. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Perri F, Lazzari G, Scarpati GD and
Silvano G: Oral vinorelbine: A feasible and safe partner for
radiotherapy in the treatment of locally advanced non-small cell
lung cancer. Onco Targets Ther. 9:2359–2364. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Diaby V, Tawk R, Sanogo V, Xiao H and
Montero AJ: A review of systematic reviews of the
cost-effectiveness of hormone therapy, chemotherapy, and targeted
therapy for breast cancer. Breast Cancer Res Treat. 151:27–40.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Harbeck N, Huang CS, Hurvitz S, Yeh DC,
Shao Z, Im SA, Jung KH, Shen K, Ro J, Jassem J, et al: Afatinib
plus vinorelbine versus trastuzumab plus vinorelbine in patients
with HER2-overexpressing metastatic breast cancer who had
progressed on one previous trastuzumab treatment (LUX-Breast 1): An
open-label, randomised, phase 3 trial. Lancet Oncol. 17:357–366.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mondal A, Gandhi A, Fimognari C, Atanasov
AG and Bishayee A: Alkaloids for cancer prevention and therapy:
Current progress and future perspectives. Eur J Pharmacol.
858(172472)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jonna S, Reuss JE, Kim C and Liu SV: Oral
chemotherapy for treatment of lung cancer. Front Oncol.
10(793)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rossi D, Catalano V, Alessandroni P,
Fedeli A, Fedeli SL, Giordani P, Baldelli AM, Casadei V, Ceccolini
M, Ugolini M, et al: A phase II study of single-agent oral
vinorelbine in patients with pretreated advanced non-small-cell
lung cancer. Clin Lung Cancer. 8:382–385. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Markert JE, Jasien JV, Turner DC, Huisingh
C, Girkin CA and Downs JC: IOP, IOP transient impulse, ocular
perfusion pressure, and mean arterial pressure relationships in
nonhuman primates instrumented with telemetry. Invest Ophthalmol
Vis Sci. 59:4496–4505. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ohwada K: Body surface area of the golden
Syrian hamster. Jikken Dobutsu. 41:221–224. 1992.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Oragano CA, Patton D and Moore Z:
Phlebitis in intravenous amiodarone administration: Incidence and
contributing factors. Crit Care Nurse. 39:e1–e12. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wilson BE, Jacob S, Yap ML, Ferlay J, Bray
F and Barton MB: Estimates of global chemotherapy demands and
corresponding physician workforce requirements for 2018 and 2040: A
population-based study. Lancet Oncol. 20:769–780. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bertoglio S, Cafiero F, Meszaros P,
Varaldo E, Blondeaux E, Molinelli C and Minuto M: PICC-PORT totally
implantable vascular access device in breast cancer patients
undergoing chemotherapy. J Vasc Access. 21:460–466. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bertoglio S, Faccini B, Lalli L, Cafiero F
and Bruzzi P: Peripherally inserted central catheters (PICCs) in
cancer patients under chemotherapy: A prospective study on the
incidence of complications and overall failures. J Surg Oncol.
113:708–714. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Qi F, Cheng H, Yuan X and Zhang L:
Comparison of PICC and TIVAP in chemotherapy for patients with
thyroid cancer. Oncol Lett. 20:1657–1662. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang G, Li Y, Wu C, Guo L, Hao L, Liao H,
Xiao X, Liu S and Luo L: The clinical features and related factors
of PICC-related upper extremity asymptomatic venous thrombosis in
cancer patients: A prospective study. Medicine (Baltimore).
99(e19409)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Picardi M, Della Pepa R, Cerchione C,
Pugliese N, Mortaruolo C, Trastulli F, Giordano C, Grimaldi F,
Zacheo I, Raimondo M, et al: A frontline approach with peripherally
inserted versus centrally inserted central venous catheters for
remission induction chemotherapy phase of acute myeloid leukemia: A
randomized comparison. Clin Lymphoma Myeloma Leuk. 19:e184–e194.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ng VL: Prothrombin time and partial
thromboplastin time assay considerations. Clin Lab Med. 29:253–263.
2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tripodi A: Prothrombin time international
normalized ratio monitoring by self-testing. Curr Opin Hematol.
11:141–145. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yang DT, Robetorye RS and Rodgers GM: Home
prothrombin time monitoring: A literature analysis. Am J Hematol.
77:177–186. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Naghadeh HT, Maghsudloo M and Tabatabaei
MR: Coagulation factors V, VIII, and X, prothrombin time and
activated partial thromboplastin time test results in thawed plasma
stored at 1-6˚C for 5 days. Blood Transfus. 9:95–98.
2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Onundarson PT, Francis CW, Indridason OS,
Arnar DO, Bjornsson ES, Magnusson MK, Juliusson SJ, Jensdottir HM,
Vidarsson B, Gunnarsson PS, et al: Fiix-prothrombin time versus
standard prothrombin time for monitoring of warfarin
anticoagulation: A single centre, double-blind, randomised,
non-inferiority trial. Lancet Haematol. 2:e231–240. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gusella M, Pasini F, Caruso D, Barile C,
Modena Y, Fraccon AP, Bertolaso L, Menon D, Crepaldi G, Bononi A,
et al: Clinical outcomes of oral metronomic vinorelbine in advanced
non-small cell lung cancer: Correlations with pharmacokinetics and
MDR1 polymorphisms. Cancer Chemother Pharmacol. 83:493–500.
2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yao Z, Zhang Y and Wu H: Regulation of
C-reactive protein conformation in inflammation. Inflamm Res.
68:815–823. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pathak A and Agrawal A: Evolution of
C-reactive protein. Front Immunol. 10(943)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Setiadi H, Yago T, Liu Z and McEver RP:
Endothelial signaling by neutrophil-released oncostatin M enhances
P-selectin-dependent inflammation and thrombosis. Blood Adv.
3:168–183. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wei Y, Chen X, Shen H, Wu W, Cao G, Chen
W, Wang Y, Shen H, Yu S and Zhang J: P-selectin level at first and
third day after portal hypertensive splenectomy for early
prediction of portal vein thrombosis in patients with cirrhosis.
Clin Appl Thromb Hemost. 24 (9_Suppl):76S–83S. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Riva N, Camporese G, Iotti M, Bucherini E,
Righini M, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C,
Prandoni P, et al: Age-adjusted D-dimer to rule out deep vein
thrombosis: Findings from the PALLADIO algorithm. J Thromb Haemost.
16:271–278. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wells PS, Anderson DR, Rodger M, Forgie M,
Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ,
et al: Evaluation of D-dimer in the diagnosis of suspected
deep-vein thrombosis. N Engl J Med. 349:1227–1235. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Orlandi P, Banchi M, Alì G, Desidero TD,
Fini E, Fontanini G and Bocci G: Active metronomic vinorelbine
schedules decrease plasma interleukin-2 levels in mice with Lewis
lung carcinoma. J Chemother. 33:198–202. 2021.PubMed/NCBI View Article : Google Scholar
|
